PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA.\', \'Beijing Institute of Microbiology and Epidemiology, Beijing, China.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China.\', \'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA. sjiang@nybc.org.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China. sjiang@nybc.org.\', \'Beijing Institute of Microbiology and Epidemiology, Beijing, China. yszhou@bmi.ac.cn.\', \'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA. ldu@nybc.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41423-020-0400-4
?:hasPublicationType
?:journal
  • Cellular & molecular immunology
is ?:pmid of
?:pmid
?:pmid
  • 32203189
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all